Alliance Pharma (LON:APH) Hits New 1-Year High - What's Next?

Alliance Pharma plc (LON:APH - Get Free Report) reached a new 52-week high on Thursday . The company traded as high as GBX 61.60 ($0.76) and last traded at GBX 61.40 ($0.76), with a volume of 519622 shares changing hands. The stock had previously closed at GBX 61.20 ($0.76).

Analyst Upgrades and Downgrades

Separately, Berenberg Bank lowered Alliance Pharma to a "hold" rating and lowered their target price for the company from GBX 7,000 ($86.51) to GBX 6,250 ($77.24) in a research note on Wednesday, January 29th.

Alliance Pharma Stock Performance

The company has a debt-to-equity ratio of 47.46, a quick ratio of 1.42 and a current ratio of 2.93. The business has a 50 day moving average price of GBX 52.53 and a two-hundred day moving average price of GBX 45.48. The company has a market cap of £331.91 million, a P/E ratio of -1,023.33, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.